MedJ Takes You to WCLC 2025
David Planchard, MD, Gustave Roussy Cancer Center, France. In-Depth Analysis of FLAURA2 Final OS Results, Revealing How Osimertinib Combined with Chemotherapy Reshapes the First-Line Treatment Landscape for EGFR-Mutated Lung Cancer!